HSE criticised for 'very unfair' underspend on new drug products
Fianna Fáil MEP Billy Kelleher: 'The new minister for health must issue a directive to the HSE to ensure that new money for new medicines is spent on exactly that.' Picture: Sam Boal/RollingNews.ie
The HSE has been criticised for spending a third of its budget for new medicines on existing drugs in recent years.
Data from the HSE shows there was €98m earmarked for spending on new drug products for the health system between 2021 and 2023.



